Abstract

Although the first application of Quality by Design (QbD) concept started for product development studies, the number of studies regarding its application to analytical development has been increased recently. Basically, QbD strategy in both formulation development and analytic studies are identical logically and conceptually, but they have somedifferences in terms of its terminology and application. Essential terminology and approach differences in this concept are; the determination of the analytic target profile, critical method characteristics, critical process parameters, and the determination of the method study area. However, the risk evaluation method which is necessary for the appropriate application of quality by design is also an inseparable part of the analytical quality by design. Despite those terminological differences, developing a qualitybased method with the analytical design that contributes to research with an appropriately applied risk-based design quality approach and provides multiple advantages that will be noticed each and every time, will be useful both for researchers and authorities who investigate license documentation and changes. Therefore, the terminology which is used for analytic quality by design and appropriate risk evaluation approaches are explained in this study.

Highlights

  • Quality by Design (QbD) in Pharmaceutical Industry QbD Concept means checking production through a total understanding of the process to reduce the risk for the patient and related with it, is an evaluation of the product quality control with a scientific-based approach (Zhang & Mao, 2017)

  • The production process and parameters, specifications, and methods are determined by using a few pilot production serials which are used for authority license application and in R&D studies

  • It is observed that 69% of the pharmaceutical companies are using the Analytical Quality by Design Studies (AQbD) approach according to a questionary study performed on among the pharmaceutical companies

Read more

Summary

Introduction

Quality by Design (QbD) in Pharmaceutical Industry QbD Concept means checking production through a total understanding of the process to reduce the risk for the patient and related with it, is an evaluation of the product quality control with a scientific-based approach (Zhang & Mao, 2017). This concept was brought to the pharmaceutical agenda for the first time in 2004 with a different point of view inside the ICH Q8 guideline (ICHQ8, 2014). Most of the production processes, in-process control and product specifications, or other changes are validated in scale-up productionor industrial production

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call